Drugs / ULABTKA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00296036 | Jun 2006 → Jul 2009 | breast cancer, chemotherapy-induced toxicity | Alliance for Clinical Trials in Oncology | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ULABTKA | “a urea/lactic acid-based topical keratolytic agent (ULABTKA) may prevent HFS” PMID 21060036 ↗ Nov 2010 |
| Known as | urea/lactic acid-based topical cream | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00296036 ↗ |
| Route | Topical | “Applied topically” NCT00296036 ↗ |